Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY | BSE: 500124
₹1,331.20
₹-5.50
(-0.41%)
As on 18-May-2026IST
Market cap
₹1,11,126 Cr
Revenue (TTM)
₹33,700 Cr
P/E Ratio
26.5
P/B Ratio
2.9
Div. Yield
0.6 %
Quality Score
8/10
Growth Score
4/10
Valuation Score
5/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4,196 Cr
-
ROE
18.6 %
-
ROCE
23.3 %
-
Industry P/E
33.65
-
EV/EBITDA
14.6
-
Debt to Equity
0
-
Book Value
₹454
-
EPS
₹50.3
-
Face value
1
-
Shares outstanding
834,656,970
10 Years Aggregate
CFO
₹34,519.20 Cr
EBITDA
₹44,523.80 Cr
Net Profit
₹28,197.80 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
| 4.7 | 7.7 | 3.6 | 8.2 | 14.1 | 4.9 | 8.2 |
|
BSE Sensex
| -11.1 | -4.0 | -9.7 | -8.5 | 7.0 | 8.7 | 11.3 |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
| -7.1 | 19.3 | 36.8 | -13.6 | -6.4 | 80.8 | 10.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr. Reddy'S Labs
|
1,331.2 | 1,11,126.2 | 33,700.2 | 4,144.2 | 13.0 | 11.4 | 26.5 | 2.9 |
| 27,925.0 | 59,344.9 | 6,929.1 | 1,552.0 | 26.2 | 35.3 | 38.2 | 12.4 | |
| 3,214.1 | 40,117.5 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38 | 8.9 | |
| 426.3 | 69,075.0 | 16,927.0 | 368.8 | 8.8 | -0.6 | 179.1 | 2.0 | |
| 1,986.1 | 15,107.7 | 2,187.2 | 649.7 | 31.5 | 19 | 23.6 | 4.2 | |
| 1,426.2 | 1,15,240.8 | 28,162.6 | 3,869.8 | 16.6 | 12.1 | 29.7 | 3.3 | |
| 2,389.8 | 40,475.3 | 3,821.7 | 1,036.0 | 32.5 | 51.4 | 39.1 | 17.9 | |
| 2,125.3 | 34,116.3 | 4,147.8 | 709.5 | 22.3 | 18.3 | 48.1 | 8.2 | |
| 2,252.4 | 1,03,010.7 | 27,958.0 | 5,355.5 | 26.6 | 27.4 | 19.3 | 4.6 | |
| 4,859.3 | 22,234.1 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.8 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All News
A hunt for quality large caps available cheap
3 min read•By Jugal Harpalani
2 min read•By Mohammed Ekramul Haque
3 min read•By Research Desk
Who wins in India: Value or Growth?
3 min read•By Kumar Shankar Roy
FIIs Vs DIIs: Different strokes
3 min read•By Kumar Shankar Roy
Grab top stocks quoting at a discount
2 min read•By Mohammed Ekramul Haque
About Dr. Reddy'S Labs
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The... company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Read more
-
Incorporated
1984
-
Chairman
K Satish Reddy
-
Managing Director
GV Prasad
-
Group
Dr. Reddy's
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Dr. Reddy's Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board to consider Dividend
12-May-2026No News & Announcements are available.
FAQs for Dr. Reddy'S Labs
What is the current share price of Dr Reddy's Laboratories Ltd Today?
The share price of Dr Reddy's Laboratories Ltd is ₹1,331.20 (NSE) and ₹1,331.40 (BSE) as of 18-May-2026 IST. Dr Reddy's Laboratories Ltd has given a return of 14.09% in the last 3 years.
What is the current PB & PE ratio of Dr Reddy's Laboratories Ltd?
The P/E ratio of Dr Reddy's Laboratories Ltd is 26.48 times as on 18-May-2026, a 21 discount to its peers’ median range of 33.65 times.
The P/B ratio of Dr Reddy's Laboratories Ltd is 2.93 times as on 18-May-2026, a 36 discount to its peers’ median range of 4.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.87
|
2.86
|
|
2024
|
3.68
|
3.65
|
|
2023
|
3.42
|
3.33
|
|
2022
|
32.83
|
3.76
|
|
2021
|
38.50
|
4.29
|
What is the 52 Week High and Low of Dr Reddy's Laboratories Ltd?
The 52-week high and low of Dr Reddy's Laboratories Ltd are Rs 1,379.70 and Rs 1,148.40 as of 19-May-2026.
What is the market cap of Dr Reddy's Laboratories Ltd?
Dr Reddy's Laboratories Ltd has a market capitalisation of ₹ 1,11,126 Cr as on 18-May-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Dr Reddy's Laboratories Ltd?
Before investing in Dr Reddy's Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.